Nisa Investment Advisors
ISEE

Nisa Investment Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Nisa Investment Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,440
Closed -$175K – 2893
2023
Q2 		$175K Buy
4,440
+238
+6% +$8.4K ﹤0.01% 1362
2023
Q1 		$102K Sell
4,202
-400
-9% -$8.76K ﹤0.01% 1501
2022
Q4 		$99K Hold
4,602
– – ﹤0.01% 1565
2022
Q3 		$110K Buy
4,602
+82
+2% +$1.08K ﹤0.01% 1462
2022
Q2 		$43K Buy
4,520
+1,290
+40% +$16.2K ﹤0.01% 1785
2022
Q1 		$54K Buy
3,230
+870
+37% +$12.9K ﹤0.01% 1822
2021
Q4 		$33K Buy
+2,360
New +$38.7K ﹤0.01% 1829
2016
Q4 		– Sell
-500
Closed -$23K – 1904
2016
Q3 		$23K Buy
500
+200
+67% +$11.3K ﹤0.01% 1612
2016
Q2 		$15K Hold
300
– – ﹤0.01% 1715
2016
Q1 		$13K Buy
+300
New +$15.3K ﹤0.01% 1733

Nisa Investment Advisors's ISEE Position: Q3 2023 in Review

Nisa Investment Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 4,440 shares — an estimated $175K sold.

Nisa Investment Advisors first reported a position in ISEE in Q1 2016 and held it in 10 quarters. The position peaked at $175K in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Nisa Investment Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Nisa Investment Advisors sold 4,440 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $175K.
  • Nisa Investment Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
  • Nisa Investment Advisors's IVERIC bio, Inc. Common Stock position peaked at $175K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Nisa Investment Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.